Log in

NYSE:NVSNovartis News Headlines

$87.43
+1.15 (+1.33 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$85.82
Now: $87.43
$87.59
50-Day Range
$83.41
MA: $85.89
$89.78
52-Week Range
$69.18
Now: $87.43
$99.84
Volume2.56 million shs
Average Volume1.64 million shs
Market Capitalization$200.37 billion
P/E Ratio16.69
Dividend Yield2.33%
Beta0.51

Headlines

Novartis (NYSE NVS) News Headlines

Source:
DateHeadline
Coronavirus live updates: Cuomo backs businesses over face masks, children grapple with the virus - NBCNews.comCoronavirus live updates: Cuomo backs businesses over face masks, children grapple with the virus - NBCNews.com
www.nbcnews.com - May 30 at 1:09 AM
Novartis Inks Deal to Make Experimental Coronavirus VaccineNovartis Inks Deal to Make Experimental Coronavirus Vaccine
www.wsj.com - May 29 at 10:06 AM
Novartis to make COVID-19 vaccine developed by Massachusetts scientistsNovartis to make COVID-19 vaccine developed by Massachusetts scientists
seekingalpha.com - May 29 at 10:06 AM
Novartis: CHMP Recommends Approval Of Piqray - Quick FactsNovartis: CHMP Recommends Approval Of Piqray - Quick Facts
www.nasdaq.com - May 29 at 10:06 AM
Novartis Tafinlar + Mekinist shows long-term survival benefit in melanomaNovartis' Tafinlar + Mekinist shows long-term survival benefit in melanoma
seekingalpha.com - May 29 at 10:06 AM
Novartis to make experimental coronavirus vaccine - MarketWatchNovartis to make experimental coronavirus vaccine - MarketWatch
www.marketwatch.com - May 28 at 11:06 PM
Novartis to Manufacture Mass Generals Coronavirus Vaccine Candidate - Motley FoolNovartis to Manufacture Mass General's Coronavirus Vaccine Candidate - Motley Fool
www.fool.com - May 28 at 6:06 PM
Novartis to Manufacture Mass Generals Coronavirus Vaccine CandidateNovartis to Manufacture Mass General's Coronavirus Vaccine Candidate
finance.yahoo.com - May 28 at 6:06 PM
Big Day for Data: GDP, Jobless Claims, Novartis, Durable Goods & More - Yahoo FinanceBig Day for Data: GDP, Jobless Claims, Novartis, Durable Goods & More - Yahoo Finance
finance.yahoo.com - May 28 at 1:06 PM
Novartis to make U.S. researchers COVID-19 gene therapy vaccine hopeful - ReutersNovartis to make U.S. researchers' COVID-19 gene therapy vaccine hopeful - Reuters
www.reuters.com - May 28 at 1:06 PM
The Petri Dish: Biopharma bidding war and Novartis exec jumps to Flagship - Boston Business JournalThe Petri Dish: Biopharma bidding war and Novartis exec jumps to Flagship - Boston Business Journal
www.bizjournals.com - May 28 at 1:06 PM
Coronavirus update: Novartis enters vaccine race as reopenings, testing efforts ramp up - Yahoo MoneyCoronavirus update: Novartis enters vaccine race as reopenings, testing efforts ramp up - Yahoo Money
finance.yahoo.com - May 28 at 1:06 PM
Novartis to make U.S. researchers COVID-19 gene therapy vaccine hopefulNovartis to make U.S. researchers' COVID-19 gene therapy vaccine hopeful
finance.yahoo.com - May 28 at 1:06 PM
Big Day for Data: GDP, Jobless Claims, Novartis, Durable Goods & MoreBig Day for Data: GDP, Jobless Claims, Novartis, Durable Goods & More
finance.yahoo.com - May 28 at 1:06 PM
Coronavirus update: Novartis enters vaccine race as reopenings, testing efforts ramp upCoronavirus update: Novartis enters vaccine race as reopenings, testing efforts ramp up
finance.yahoo.com - May 28 at 1:06 PM
Novartis: Ofatumumab Data Show Efficacy, Safety In Treatment Of Multiple SclerosisNovartis: Ofatumumab Data Show Efficacy, Safety In Treatment Of Multiple Sclerosis
www.nasdaq.com - May 28 at 7:59 AM
Novartis AG (NYSE:NVS) Given Average Recommendation of "Hold" by BrokeragesNovartis AG (NYSE:NVS) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - May 27 at 4:49 AM
Novartis AG (NYSE:NVS) Sees Significant Drop in Short InterestNovartis AG (NYSE:NVS) Sees Significant Drop in Short Interest
www.americanbankingnews.com - May 23 at 4:43 PM
Novartis (NYSE:NVS) Getting Somewhat Positive News Coverage, Analysis ShowsNovartis (NYSE:NVS) Getting Somewhat Positive News Coverage, Analysis Shows
www.americanbankingnews.com - May 17 at 3:34 AM
Drugmakers get hooked on dataDrugmakers get hooked on data
finance.yahoo.com - May 16 at 1:15 AM
Novartis CEO says any new coronavirus vaccine will take two years: newspaperNovartis CEO says any new coronavirus vaccine will take two years: newspaper
finance.yahoo.com - May 15 at 10:13 AM
Novartis Singapore returns Job Support Scheme payout worth SGD3.7 Million; aids community efforts against COVID-19 - Yahoo FinanceNovartis Singapore returns Job Support Scheme payout worth SGD3.7 Million; aids community efforts against COVID-19 - Yahoo Finance
finance.yahoo.com - May 14 at 8:14 AM
Top 5 Things to Know in the Market on Thursday, May 14thTop 5 Things to Know in the Market on Thursday, May 14th
finance.yahoo.com - May 14 at 8:14 AM
Novartis Stock Shows Rising Relative Strength; Mostly V-Shape Recovery From Covid CrashNovartis Stock Shows Rising Relative Strength; Mostly V-Shape Recovery From Covid Crash
finance.yahoo.com - May 12 at 8:24 PM
Novartis (NYSE:NVS) Rating Reiterated by UBS GroupNovartis (NYSE:NVS) Rating Reiterated by UBS Group
www.americanbankingnews.com - May 11 at 6:35 PM
Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology - Business WireDyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology - Business Wire
www.businesswire.com - May 11 at 7:27 AM
FDA OKs Novartis Tabrecta for certain lung cancer patientsFDA OKs Novartis' Tabrecta for certain lung cancer patients
seekingalpha.com - May 6 at 3:45 PM
UPDATE 1-U.S. FDA approves Novartis drug for a hard-to-treat type of lung cancer - ReutersUPDATE 1-U.S. FDA approves Novartis drug for a hard-to-treat type of lung cancer - Reuters
www.reuters.com - May 6 at 3:45 PM
Novartis announces FDA approval of MET inhibitor Tabrecta™ for metastatic non-small cell lung cancer with METex14 - GlobeNewswireNovartis announces FDA approval of MET inhibitor Tabrecta™ for metastatic non-small cell lung cancer with METex14 - GlobeNewswire
www.globenewswire.com - May 6 at 3:45 PM
Novartis AG (NVS): Were Hedge Funds Right About This Stock? - Yahoo FinanceNovartis AG (NVS): Were Hedge Funds Right About This Stock? - Yahoo Finance
finance.yahoo.com - May 4 at 4:47 PM
Novartis AG (NVS): Were Hedge Funds Right About This Stock?Novartis AG (NVS): Were Hedge Funds Right About This Stock?
finance.yahoo.com - May 4 at 4:47 PM
Should You Buy Global Blood Therapeutics Before This Week's Earnings?Should You Buy Global Blood Therapeutics Before This Week's Earnings?
finance.yahoo.com - May 4 at 11:46 AM
Cushings Syndrome Pipeline Insight, 2020 Featuring Novartis Pharmaceuticals, Cortendo AB, Corcept Therapeutics and HRA Pharma - ResearchAndMarkets.com - Yahoo FinanceCushing's Syndrome Pipeline Insight, 2020 Featuring Novartis Pharmaceuticals, Cortendo AB, Corcept Therapeutics and HRA Pharma - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - May 1 at 9:11 PM
Cushings Syndrome Pipeline Insight, 2020 Featuring Novartis Pharmaceuticals, Cortendo AB, Corcept Therapeutics and HRA Pharma - ResearchAndMarkets.com - Business WireCushing's Syndrome Pipeline Insight, 2020 Featuring Novartis Pharmaceuticals, Cortendo AB, Corcept Therapeutics and HRA Pharma - ResearchAndMarkets.com - Business Wire
www.businesswire.com - May 1 at 4:11 PM
European advisory group backs Novartis asthma inhalers - Seeking AlphaEuropean advisory group backs Novartis asthma inhalers - Seeking Alpha
seekingalpha.com - May 1 at 9:45 AM
Biotech Amgen Is Tackling Coronavirus From Two Sides — But Is It A Buy?Biotech Amgen Is Tackling Coronavirus From Two Sides — But Is It A Buy?
finance.yahoo.com - May 1 at 9:45 AM
Novartis Receives CHMP Positive Opinion For Enerzair Breezhaler - NasdaqNovartis Receives CHMP Positive Opinion For Enerzair Breezhaler - Nasdaq
www.nasdaq.com - May 1 at 4:45 AM
Novartis Wins Expanded European OK for Cosentyx Amid Pursuit of $5 Billion Sales - The New York TimesNovartis Wins Expanded European OK for Cosentyx Amid Pursuit of $5 Billion Sales - The New York Times
www.nytimes.com - May 1 at 4:45 AM
Novartis Cosentyx® gains fourth indication in EU with first-in-class approval in axial spondyloarthritis spectrum - GlobeNewswireNovartis Cosentyx® gains fourth indication in EU with first-in-class approval in axial spondyloarthritis spectrum - GlobeNewswire
www.globenewswire.com - April 29 at 2:43 AM
Novartis wins expanded European OK for Cosentyx amid pursuit of $5 billion salesNovartis wins expanded European OK for Cosentyx amid pursuit of $5 billion sales
finance.yahoo.com - April 29 at 2:43 AM
Novartis maintains strong operational performance in Q1, confirms FY 2020 guidance at this time, and advances a broad range of efforts to support the global response to COVID-19 - GlobeNewswireNovartis maintains strong operational performance in Q1, confirms FY 2020 guidance at this time, and advances a broad range of efforts to support the global response to COVID-19 - GlobeNewswire
www.globenewswire.com - April 28 at 9:35 PM
Novartis (NVS) Q1 Earnings and Revenues Surpass EstimatesNovartis (NVS) Q1 Earnings and Revenues Surpass Estimates
finance.yahoo.com - April 28 at 11:32 AM
Novartis Stock Dives Alongside Pharma Peers Despite First-Quarter BeatNovartis Stock Dives Alongside Pharma Peers Despite First-Quarter Beat
finance.yahoo.com - April 28 at 11:32 AM
Novartis posts first-quarter sales, profit beat as COVID-19 spurs prescriptionsNovartis posts first-quarter sales, profit beat as COVID-19 spurs prescriptions
finance.yahoo.com - April 28 at 4:18 AM
Top Research Reports for Intel, Novartis & Toyota - NasdaqTop Research Reports for Intel, Novartis & Toyota - Nasdaq
www.nasdaq.com - April 27 at 11:17 PM
Coronavirus update: US death toll tops 50K as Trump stirs debate over treatments, reopeningsCoronavirus update: US death toll tops 50K as Trump stirs debate over treatments, reopenings
finance.yahoo.com - April 26 at 7:18 PM
Factors Setting the Tone for Novartis (NVS) Q1 Earnings - NasdaqFactors Setting the Tone for Novartis' (NVS) Q1 Earnings - Nasdaq
www.nasdaq.com - April 23 at 11:52 PM
Factors Setting the Tone for Novartis (NVS) Q1 Earnings - Yahoo FinanceFactors Setting the Tone for Novartis' (NVS) Q1 Earnings - Yahoo Finance
finance.yahoo.com - April 23 at 1:51 PM
Hydroxychloroquine sparks renewed controversy but clinical trials are pushing aheadHydroxychloroquine sparks renewed controversy but clinical trials are pushing ahead
finance.yahoo.com - April 23 at 1:51 PM
BRIEF-Novartis Announces Data Showing Jakavi More Effective In Acute Graft-Versus-Host Disease - ReutersBRIEF-Novartis Announces Data Showing Jakavi More Effective In Acute Graft-Versus-Host Disease - Reuters
www.reuters.com - April 22 at 5:48 PM
This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.